Palisade Bio (PALI) Revenue (QoQ) (2011 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -58.47% |
| Mar 31, 2020 | 140.80% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | -68.33% |
| Jun 30, 2019 | 215.76% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | -99.01% |
| Jun 30, 2018 | 10,000.00% |
| Mar 31, 2018 | -99.01% |
| Dec 31, 2017 | 10,000.00% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -71.42% |
| Dec 31, 2016 | 249.84% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | -14.30% |
| Mar 31, 2015 | -37.48% |
| Dec 31, 2014 | -6.68% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | 19.99% |
| Mar 31, 2014 | 66.68% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.00% |
| Jun 30, 2013 | -97.56% |
| Mar 31, 2013 | 4,000.00% |
| Dec 31, 2012 | -98.54% |
| Sep 30, 2012 | 118.67% |
| Jun 30, 2012 | -50.00% |
| Mar 31, 2012 | -45.60% |
| Dec 31, 2011 | 177.72% |